Targeting the nf-κb pathway enhances responsiveness of mammary tumors to jak inhibitors

HIGHLIGHTS

• who: Aditi S. Bapat from the Molecular Pharmacology and Therapeutics Graduate Program, University ofMinneapolis, MN, USA have published the research work: Targeting the NF-u03baB pathway enhances responsiveness of mammary tumors to JAK inhibitors, in the Journal: Scientific Reports Scientific Reports
• what: The study shows that this off-cell-type targeting can lead to development of resistance to tumor-targeted therapy and targeting the TME in combination with the tumor cells may be beneficial. | Vol:.(1234567890) 13:5349 | | 13:5349 | 9 Vol.:(0123456789) | Vol:.(1234567890) 13:5349 | | 13:5349 | 11 Vol.:(0123456789)

SUMMARY . . .

 

If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.